Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Renaud Seigneuric
Affiliation
INSERM
ORCID
Career Start Year
1997
Papers
32
H Index
19
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
33506516
Nanofitins targeting heat shock protein 110: An innovative immunotherapeutic modality in cancer.
Int J Cancer
2021
33054049
XPO1 regulates erythroid differentiation and is a new target for the treatment of β-thalassemia.
Haematologica
2020
27819670
HSP110 promotes colorectal cancer growth through STAT3 activation.
Oncogene
2017
28166442
Exosomes in cancer theranostic: Diamonds in the rough.
Cell Adh Migr
2017
28352659
Serum Gp96 is a chaperone of complement-C3 during graft-versus-host disease.
JCI Insight
2017
28186505
N-glycosylation of mouse TRAIL-R and human TRAIL-R1 enhances TRAIL-induced death.
Cell Death Differ
2017
27826540
Editorial: Tumor-Derived Extracellular Vesicles: Protocols, Models, and Clinical Evidence.
Front Oncol
2016
27611846
A self-inducible heterologous protein expression system in Escherichia coli.
Sci Rep
2016
25030382
C-terminal amino acids are essential for human heat shock protein 70 dimerization.
Cell Stress Chaperones
2015
26598503
Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.
J Natl Cancer Inst
2015
25653112
Dose-dependent biphasic leptin-induced proliferation is caused by non-specific IL-6/NF-κB pathway activation in human myometrial cells.
Br J Pharmacol
2015
24164191
Quantifying Gp96/Grp94 complexes preparations for vaccines: a key step often inaccurate.
Curr Med Chem
2014
25156257
HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia.
Nature
2014
24512910
Patients with colorectal tumors with microsatellite instability and large deletions in HSP110 T17 have improved response to 5-fluorouracilâ¿¿based chemotherapy.
Gastroenterology
2014
21078542
Targeting heat shock proteins in cancer.
Cancer Lett
2013
22356756
The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer.
Radiother Oncol
2012
23185449
Molecular pathways involved in prostate carcinogenesis: insights from public microarray datasets.
PLoS One
2012
22449631
The small heat shock proteins family: the long forgotten chaperones.
Int J Biochem Cell Biol
2012
21709317
Targeting cancer with peptide aptamers.
Oncotarget
2011
22649762
Heat shock proteins as danger signals for cancer detection.
Front Oncol
2011
21719133
Translational control is a major contributor to hypoxia induced gene expression.
Radiother Oncol
2011
20712588
From nanotechnology to nanomedicine: applications to cancer research.
Curr Mol Med
2010
19293465
Intra-voxel heterogeneity influences the dose prescription for dose-painting with radiotherapy: a modelling study.
Phys Med Biol
2009
18985037
Robust prognostic value of a knowledge-based proliferation signature across large patient microarray studies spanning different cancer types.
Br J Cancer
2008
17531340
Proteomic analysis of gene expression following hypoxia and reoxygenation reveals proteins involved in the recovery from endoplasmic reticulum and oxidative stress.
Radiother Oncol
2007
17532074
Impact of supervised gene signatures of early hypoxia on patient survival.
Radiother Oncol
2007
16467844
Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control.
EMBO J
2006
16098621
The hypoxic proteome is influenced by gene-specific changes in mRNA translation.
Radiother Oncol
2005
16583269
Simulated interactions between a Class III antiarrhythmic drug and a figure 8 reentry.
Acta Biotheor
2005
10194932
Role of the dispersion of refractoriness on cardiac reentries.
Math Biosci
1999
10855267
Incidence of dispersion of refractoriness and cellular coupling resistance on cardiac reentries and ventricular fibrillation.
Acta Biotheor
1999
9436297
Theoretical study of cardiac transient conduction blocks on reentries induction. Applications to antiarrhythmic drugs.
Acta Biotheor
1997
1 - 32 of 32
Column Actions
Search
Recommended Authors
Daniel D'Andrea
Nottingham Trent University
Career Start Year
2010
Number of shared co-authors
0
Isabelle Martins
Universite de Paris, Sorbonne Universite, Inserm U8, Institut Universitaire de France
Career Start Year
2007
Number of shared co-authors
0
Eric Paquet
University of Laval
Career Start Year
2007
Number of shared co-authors
0
Jordi Rodon
The University of Texas MD Anderson Cancer Center
Career Start Year
2006
Number of shared co-authors
0
Henrik J Johansson
Karolinska Institutet
Career Start Year
2005
Number of shared co-authors
0
Nan Du
Institute for Solid State Physics, Friedrich Schiller University Jena
Career Start Year
2003
Number of shared co-authors
0
Reza Ghasemi
Washington University School of Medicine
Career Start Year
2003
Number of shared co-authors
0
Ting-Ting Wu
Xinjiang Medical University Affiliated First Hospital
Career Start Year
2000
Number of shared co-authors
0
Pingfu Fu
Case Western Reserve University
Career Start Year
2000
Number of shared co-authors
0
Kerby Shedden
University of Michigan ann arbor
Career Start Year
1999
Number of shared co-authors
0
Gaurav Pandey
Sanjay Gandhi Post Graduate Institute of Medical Sciences
Career Start Year
1999
Number of shared co-authors
0
Chandra C Ghosh
The Wistar Institute
Career Start Year
1999
Number of shared co-authors
0
Rong Fan
Institute of Pathogens and Vectors, Dali University
Career Start Year
1998
Number of shared co-authors
0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year
1997
Number of shared co-authors
0
Hai Hu
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Career Start Year
1996
Number of shared co-authors
0
Ning Guo
Beijing Tongren Hospital, Capital Medical University
Career Start Year
1995
Number of shared co-authors
0
Thomas Str??bel
Indiana University School of Medicine
Career Start Year
1994
Number of shared co-authors
0
Christian Baumgartner
Institut fur Experimentelle und Angewandte Physik, University of Regensburg
Career Start Year
1994
Number of shared co-authors
0
Jian-Hua Chen
University of California San Francisco
Career Start Year
1993
Number of shared co-authors
0
Paul N Span
Radboud University Medical Center
Career Start Year
1993
Number of shared co-authors
10
Borko Jovanovic
Robert H Lurie Comprehensive Cancer Center of Northwestern University
Career Start Year
1991
Number of shared co-authors
0
Emile E Voest
The Netherlands Cancer Institute
Career Start Year
1989
Number of shared co-authors
2
Sun Young Kim
Asan Medical Center, University of Ulsan College of Medicine
Career Start Year
1988
Number of shared co-authors
0
Stefan W??lfl
Institute of Pharmacy and Molecular Biotechnology, Heidelberg University
Career Start Year
1987
Number of shared co-authors
0
Alberto Zambelli
IRCCS Humanitas Research Hospital
Career Start Year
1987
Number of shared co-authors
0
Kenneth R Hess
The University of Texas MD Anderson Cancer Center
Career Start Year
1986
Number of shared co-authors
1
Louis Gaboury
Institute for Research in Immunology and Cancer (IRIC), University of Montreal
Career Start Year
1986
Number of shared co-authors
0
Chiara Riganti
University of Turin
Career Start Year
1985
Number of shared co-authors
1
John N Weinstein
The University of Texas MD Anderson Cancer Center
Career Start Year
1968
Number of shared co-authors
0
Karel Soucek
Institute of Biophysics of the Czech Academy of Sciences
Career Start Year
1962
Number of shared co-authors
0
row(s) 1 - 30 of 30
Collaborators
Philippe Lambin
Maastricht University
Co-authored papers
8
Bradly G Wouters
Princess Margaret Cancer Centre, University Health Network and, University of Toronto
Co-authored papers
8
Micha??l G Magagnin
GROW Research Institute, Maastricht University
Co-authored papers
6
Marianne Koritzinsky
Princess Margaret Cancer Centre University Health Network
Co-authored papers
5
Jeroen J J P van den Beucken
Radboud University Medical Center
Co-authored papers
4
Maud H W Starmans
Ontario Institute for Cancer Research
Co-authored papers
3
Chris T Evelo
Maastricht University
Co-authored papers
3
Arek Kasprzyk
Ontario Institute for Cancer Research
Co-authored papers
1
Jan Willem Voncken
Maastricht University
Co-authored papers
1
Isaure Chauvot de Beauchêne
Co-authored papers
1
Nikolajs Zeps
Queensland University of Technology
Co-authored papers
1
Andre Dekker
Maastricht University Medical Centre
Co-authored papers
1
Syed Haider
Institute of Cancer Research
Co-authored papers
1
Marie Loh
Lee Kong Chian School of Medicine, Nanyang Technological University
Co-authored papers
1
Kenneth C Chu
Ontario Institute for Cancer Research
Co-authored papers
1
Michiel E Adriaens
Maastricht University
Co-authored papers
1
Paul C Boutros
University of California los angeles
Co-authored papers
1
Adrian L Harris
University of Oxford
Co-authored papers
1
Francis Nguyen
Ontario Institute for Cancer Research
Co-authored papers
1
Adrian C Begg
The Netherlands Cancer Institute
Co-authored papers
1
Francesca M Buffa
University of Oxford
Co-authored papers
1
Bart Devreese
Laboratory of Microbiology-Protein Research Unit, Ghent University
Co-authored papers
1
1 - 22